Alcami Corporation (PRIVATE.ALCAMICORPO)

Overall impact
D (32)

Commentary

Alcami Corporation is a below-average overall performer. With a 'D' rating of 32.0 for overall impact (bottom 25% of all companies), Alcami Corporation ranks 48th out of 48 industry peers, behind Agilent, LGC Group, Pace Analytical Services and 44 others, and ahead of and -3 others. On top material causes for Alcami Corporation's industry (Health Care Providers & Services), Alcami Corporation performs well in Technology Innovation (94.9 score), Child and Maternal Health (94.8), Child and Maternal Health (94.8) and 1 other cause where it received an 'A' score and performs poorly in Accountable Institutions (14.3 score), Improved Mental Health (26.7), Fair Labor Practices (7.2) and 12 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.ALCAMICORPO
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
1,000
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Life Sciences Tools & Services
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
#<Country/State:0x00007da02b8669f8>, United States
Share classes
PRIVATE.ALCAMICORPO
Description
Alcami Corporation is a US‑based contract development and manufacturing organization (CDMO) headquartered in North Carolina that provides end-to-end pharmaceutical and biotechnology services — including integrated laboratory services, drug‑product manufacturing, cGMP storage and support (e.g., environmental monitoring) — and has over 40 years of industry experience.
Material causes
Ethos considers the following causes material for Alcami Corporation, based on its industry sub-industry Life Sciences Tools & Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.